Osteogenon in Orthopedics and Traumatology

Phase 4 Recruiting 150 enrolled University of Opole

RandomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study was to evaluate the supportive effect of the ossein-hydroxyapatite complex in fracture healing. The investigators hypothesized that the ossein-hydroxyapatite complex would positively impact fracture healing outcomes.The assessment covers clinical, radiological and biomechanical parameters.

Timeline

Start: 2024-11-01
Primary completion: 2027-02-02
Completion: 2027-12-30

Publications

Background Morasiewicz P, Zaborska M, Sobczak M, Tomczyk L, Leyko P, Bobinski A, Kochanska-Bieri J, Pili D, Kazubski K. The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures. Pharmaceuticals (Basel). 2024 Nov 14;17(11):1531. doi: 10.3390/ph17111531.
Background Morasiewicz P, Zaborska M, Sobczak M, Tomczyk L, Pili D, Kazubski K, Leyko P. The Use of Ossein-Hydroxyapatite Complex in Conjunction with the Ilizarov Method in the Treatment of Tibial Nonunion. J Clin Med. 2025 May 12;14(10):3353. doi: 10.3390/jcm14103353.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Osteogenon	Unknown	830 mg	Oral

Indications

No indication recorded.